Maravai LifeSciences (NASDAQ:MRVI) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.07) by 43.66 percent. This is a 33.33 percent increase over losses of $(0.06) per share from the same period last year. The company reported quarterly sales of $49.866 million which beat the analyst consensus estimate of $49.047 million by 1.67 percent. This is a 11.83 percent decrease over sales of $56.558 million the same period last year.